The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents

Source: Critical Care - Category: Intensive Care Authors: Tags: Letter Source Type: research